Study of a BALB/c Mouse Model for Allergic Asthma

Area of Science:

• Immunology
• Pulmonology
• Animal Models

Background:

• Allergic asthma is a significant global health issue characterized by airway inflammation, eosinophilia, and mucus hypersecretion.
• Mouse models are crucial for understanding asthma's complex mechanisms and for testing therapeutic interventions.

Purpose of the Study:

• To compare the efficacy of three distinct ovalbumin-induced mouse models in replicating key features of human allergic asthma.
• To identify the most suitable mouse model for studying asthma pathobiology and evaluating potential treatments.

Main Methods:

• Three groups of mice were utilized, differing in their ovalbumin (OVA) sensitization and aerosol challenge protocols.
• Asthma induction was assessed by measuring white blood cell and eosinophil counts, Th2 cytokine levels (IL-4, IL-13) in bronchoalveolar lavage fluid (BALF), serum immunoglobulin E (IgE) levels, and lung histopathology.

Main Results:

• Group I, treated with OVA intraperitoneal injection followed by aerosol challenge, exhibited significantly higher total white blood cells, eosinophils, Th2 cytokines, and IgE levels compared to other groups.
• Histopathological analysis of Group I mice revealed increased inflammatory cell infiltration in peribronchial and perivascular areas and a greater number of mucus-producing goblet cells.

Conclusions:

• The OVA sensitization and challenge model (Group I) effectively recapitulates key pathological features of human allergic asthma, including airway inflammation and mucus hypersecretion.
• This model serves as a valuable tool for investigating asthma pathobiology and for the preclinical evaluation of novel asthma therapies.